Hostname: page-component-76fb5796d-2lccl Total loading time: 0 Render date: 2024-04-25T09:29:04.429Z Has data issue: false hasContentIssue false
  • English
  • Français

Familial and sporadic schizophrenia: a comparison of somatic diseases and abuse in patients and their relatives

Published online by Cambridge University Press:  24 June 2014

Kristina Melkersson
Kristina Melkersson*
Affiliation:
Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden
*
Kristina Melkersson, Department of Molecular Medicine and Surgery, Karolinska Institute, c/o Sollentuna Psychiatric Polyclinic, Nytorpsvägen 10, SE-191 35 Sollentuna, Sweden. Tel: +46 8 58730405; Fax: +46 8 351318; E-mail: kristina.melkersson@ki.se
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

Comparing schizophrenia patients on the basis of familial and non-familial forms of the illness provides a promising approach to the identification of genes involved in schizophrenia. The aim of this study was to search for somatic factors that discriminate between patients with and without a family history of schizophrenia and between their relatives.

Methods:

Ninety-five schizophrenia patients were structurally interviewed about mental and physical health and alcohol and substance use in themselves and their families. Besides this, complementary information was obtained from the patients’ case records. Patients with (41%) and without (59%) a family history were then compared.

Results:

The main differences were found in the patients’ relatives. Fewer patients with a family history, compared with patients without a family history, had relatives with cancer (p = 0.002). Conversely, there was a tendency towards that more patients with a family history, compared with patients without a family history, had relatives with cardiac infarction (p = 0.05).

Conclusion:

The genetic risk associated with schizophrenia seems to cosegregate into a factor(s) that protects against cancer and possibly also increases the risk for cardiac infarction.

Keywords

cancercardiac infarctionfamily historygeneticsschizophrenia
Type
Research Article
Information
Acta Neuropsychiatrica , Volume 21 , Issue 1 , February 2009 , pp. 4 - 10
Copyright
Copyright © 2009 Blackwell Munksgaard

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Gottesman, II, Shields, J. A polygenic theory of schizophrenia. Proc Natl Acad Sci U S A 1967;58:199–205. CrossRefGoogle ScholarPubMed
McGuffin, P, Owen, MJ, O’Donovan, MC. Schizophrenia. In: McGuffin, P, Owen, MJ, O’Donovan, MCet al., eds. Seminars in psychiatric genetics. London: Gaskell Press, 1994: 87–109. Google Scholar
Fanous, AH, Kendler, KS. Genetic heterogeneity, modifier genes, and quantitative phenotypes in psychiatric illness: searching for a framework. Mol Psychiatry 2005;10:6–13. CrossRefGoogle ScholarPubMed
Bleuler, M. The schizophrenia disorders (SM Clemens, Trans.). New Haven: Yale University Press, 1978. Google Scholar
Malaspina, D, Corcoran, C, Fahim, Cet al. Paternal age and sporadic schizophrenia: evidence for de novo mutations. Am J Med Genet 2002;114:299–303. CrossRefGoogle ScholarPubMed
Malaspina, D, Harlap, S, Fennig, Set al. Advancing paternal age and the risk of schizophrenia. Arch Gen Psychiatry 2001;58:361–367. CrossRefGoogle ScholarPubMed
Zammit, S, Allebeck, P, Dalman, Cet al. Paternal age and risk for schizophrenia. Br J Psychiatry 2003;183:405–408. CrossRefGoogle ScholarPubMed
Sipos, A, Rasmussen, F, Harrison, Get al. Paternal age and schizophrenia: a population based cohort study. Br Med J 2004;329:1070. CrossRefGoogle ScholarPubMed
American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn. Washington DC: American Psychiatric Press, 1994. Google Scholar
O’Keefe, DJ. Colloquy: should familywise alpha be adjusted? Against familywise alpha adjustment. Hum Commun Res 2003;29:431–447. Google Scholar
O’Keefe, DJ. Searching for defensible application of alpha-adjustment tools. Hum Commun Res 2003;29:464–468. CrossRefGoogle Scholar
Melkersson, KI, Hulting, A-L, Rane, AJ. Dose requirement and prolactin elevation of antipsychotics in male and female patients with schizophrenia or related psychoses. Br J Clin Pharmacol 2001;51:317–324. CrossRefGoogle ScholarPubMed
Woods, SW. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 2003;64:663–667. CrossRefGoogle ScholarPubMed
Norman, RMG, Manchanda, R, Malla, AK, Harricharan, R, Northcott, S. The significance of family history in first-episode schizophrenia spectrum disorder. J Nerv Ment Dis 2007;195:846–852. CrossRefGoogle ScholarPubMed
Malaspina, D, Goetz, RR, Yale, Set al. Relation of familial schizophrenia to negative symptoms but not to the deficit syndrome. Am J Psychiatry 2000;157:994–1003. CrossRefGoogle ScholarPubMed
Byrne, M, Agerbo, E, Mortensen, PB. Family history of psychiatric disorders and age at first contact in schizophrenia: an epidemiological study. Br J Psychiatry 2002;181(Suppl. 43):S19–S25. CrossRefGoogle Scholar
Strachan, T, Read, AP. Organisation and expression of the human genome. In: Strachan, T, Read, AP, eds. Human molecular genetics. Oxford: BIOS Scientific Publishers Ltd, 1996; 170–173. Google Scholar
Kendler, KS, Hays, P. Familial and sporadic schizophrenia: a symptomatic, prognostic, and EEG comparison. Am J Psychiatry 1982;139:1557–1562. Google ScholarPubMed
Schwarzkopf, SB, Nasrallah, HA, Olson, SC, Bogerts, B, McLaughlin, JA, Mitra, T. Family history and brain morphology in schizophrenia: an MRI study. Psychiatry Res 1991;40:49–60. CrossRefGoogle ScholarPubMed
Roy, M-A, Flaum, MA, Arndt, SV, Crowe, RR, Andreasen, NC. Magnetic resonance imaging in familial versus sporadic cases of schizophrenia. Psychiatry Res 1994;54:25–36. CrossRefGoogle ScholarPubMed
Jones, GRN. Cancer therapy: phenothiazines in an unexpected role (review). Tumori 1985;71:563–569. CrossRefGoogle Scholar
Kelly, C, McCreadie, RG. Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland. Am J Psychiatry 1999;156:1751–1757. CrossRefGoogle ScholarPubMed
McCreadie, RG. Diet, smoking and cardiovascular risk in people with schizophrenia. Descriptive study. Br J Psychiatry 2003;183:534–539. Google ScholarPubMed
Joukamaa, M, Heliövaara, M, Knekt, P, Aromaa, A, Raitasalo, R, Lehtinen, V. Schizophrenia, neuroleptic medication and mortality. Br J Psychiatry 2006;188:122–127. CrossRefGoogle ScholarPubMed
Lichtermann, D, Ekelund, J, Pukkala, E, Tanskanen, A, Lönnqvist, J. Incidence of cancer among persons with schizophrenia and their relatives. Arch Gen Psychiatry 2001;58:573–578. CrossRefGoogle ScholarPubMed
Levav, I, Lipshitz, I, Novikov, Iet al. Cancer risk among parents and siblings of patients with schizophrenia. Br J Psychiatry 2007;190:156–161. CrossRefGoogle ScholarPubMed
Oksbjerg Dalton, S, Munk Laursen, T, Mellemkjaer, L, Johansen, C, Mortensen, PB. Risk for cancer in parents of patients with schizophrenia. Am J Psychiatry 2004;161:903–908. CrossRefGoogle Scholar
Barak, Y, Achiron, A, Mandel, M, Mirecki, I, Aizenberg, D. Reduced cancer incidence among patients with schizophrenia. Cancer 2005;104:2817–2821. CrossRefGoogle ScholarPubMed
Goldacre, MJ, Kurina, LM, Wotton, CJ, Yeates, D, Seagroatt, V. Schizophrenia and cancer: an epidemiological study. Br J Psychiatry 2005;187:334–338. CrossRefGoogle ScholarPubMed
Grinshpoon, A, Barchana, M, Ponizovsky, Aet al. Cancer in schizophrenia: is the risk higher or lower? Schizophr Res 2005;73:333–341; Erratum: Schizophr Res 2005;78:115–116. CrossRefGoogle ScholarPubMed
Hanson, DR, Gottesman, II. Theories of schizophrenia: a genetic-inflammatory-vascular synthesis. BMC Med Genet 2005;6:7. CrossRefGoogle ScholarPubMed
Brown, S. Excess mortality of schizophrenia: a meta-analysis. Br J Psychiatry 1997;171:502–508. CrossRefGoogle ScholarPubMed
Goff, DC, Sullivan, LM, McEvoy, JPet al. A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophr Res 2005;80:45–53. CrossRefGoogle ScholarPubMed
Mukherjee, S, Schnur, DB, Reddy, R. Family history of type 2 diabetes in schizophrenic patients (letter). Lancet 1989;1:495. CrossRefGoogle Scholar
Rotter, JI, Vadheim, CM, Rimoin, DL. Genetics of diabetes mellitus. In: Rifkin, H, Porte, D, eds. Diabetes mellitus. Theory and practice. New York: Elsevier, 1990; 378–413. Google Scholar
Faraone, SV, Seidman, LJ, Kremen, WS, Toomey, R, Pepple, JR, Tsuang, MT. Neuropsychologic functioning among the nonpsychotic relatives of schizophrenic patients: the effect of genetic loading. Biol Psychiatry 2000;48:120–126. CrossRefGoogle Scholar